Pancreatic Cancer Research

ResearcherYale UniversityActive in the last 2 years

Ronald R. Salem

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2410-7665; OpenAlex author ID A5077051180. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 6

  1. Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer: A Nonrandomized Controlled Trial. First author DOI 10.1001/jamaoncol.2024.1575↗
  2. Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001919↗
  3. A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Bor… Co-author DOI 10.1097/mpa.0000000000001592↗
  4. Is There any Survival Benefit of Maintenance Chemotherapy Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer Patients with Post-Surger… Last author PMID 32982620↗
  5. Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer. Co-author DOI 10.1038/bjc.2016.45↗
  6. The novel tumor angiogenic factor, adrenomedullin-2, predicts survival in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.jss.2014.11.002↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stacey Stein · 3 shared papers, 2016–2024 · strength 0.30
  2. Jill Lacy · 3 shared papers, 2016–2024 · strength 0.30
  3. Charles H. Cha · 3 shared papers, 2015–2024 · strength 0.26
  4. John W. Kunstman · 2 shared papers, 2021–2024 · strength 0.25
  5. Michael Cecchini · 2 shared papers, 2020–2024 · strength 0.25
  6. Kimberly L. Johung · 2 shared papers, 2020–2024 · strength 0.25
  7. Martin D. Goodman · 1 shared paper, 2020 · strength 0.16
  8. Muhammad Wasif Saif · 1 shared paper, 2020 · strength 0.16
  9. Guoping Cai · 1 shared paper, 2024 · strength 0.14
  10. Luisa F. Escobar‐Hoyos · 1 shared paper, 2024 · strength 0.14
  11. Mandar Deepak Muzumdar · 1 shared paper, 2024 · strength 0.14
  12. Adham Adel Jurdi · 1 shared paper, 2024 · strength 0.14
  13. Kenneth Reed Shroyer · 1 shared paper, 2024 · strength 0.14
  14. Nesrin M. Hasan · 1 shared paper, 2021 · strength 0.11
  15. Lee Ying · 1 shared paper, 2021 · strength 0.11
  16. Ankit Chhoda · 1 shared paper, 2021 · strength 0.11
  17. Laura DeLong Wood · 1 shared paper, 2021 · strength 0.11
  18. Christopher Lee Wolfgang · 1 shared paper, 2021 · strength 0.11
  19. Nita Ahuja · 1 shared paper, 2021 · strength 0.11
  20. James J. Farrell · 1 shared paper, 2021 · strength 0.11
  21. Christine A. Iacobuzio–Donahue · 1 shared paper, 2021 · strength 0.11
  22. Adriana Blakaj · 1 shared paper, 2020 · strength 0.11
  23. Jay K. Pahade · 1 shared paper, 2020 · strength 0.11
  24. Xiaojia Guo · 1 shared paper, 2015 · strength 0.07
  25. Lindsay L. Hollander · 1 shared paper, 2015 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.